Asia Pacific Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorder...

Asia Pacific nutrigenomics market will grow by 16.9% annually with a total addressable market cap of $4,313.0 million over 2022-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relation...

44742 | Healthcare and Social Assistance

Europe Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Imm...

Europe nutrigenomics market was valued at $187.2 million in 2021 and will grow by 14.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutritio...

44742 | Healthcare and Social Assistance

North America Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorde...

North America nutrigenomics market is projected to grow by 14.8% annually in the forecast period and reach $986.4 million by 2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationshi...

44742 | Healthcare and Social Assistance

Global Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Imm...

Global nutrigenomics market will reach $2,691.3 million by 2031, growing by 15.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene...

44742 | Healthcare and Social Assistance

Asia Pacific Next-Generation Ultrasound Systems Market 2021-2031 by Component (Hardware, Software), Product Type (Diagnostic, Therapeutic), Technology (2D, 3D/4D, Others), Portability (Cart/Trolley-Ba...

Asia Pacific next-generation ultrasound systems market will grow by 9.8% annually with a total addressable market cap of $ 31,245.5 million over 2022-2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of ...

44742 | Healthcare and Social Assistance

Europe Next-Generation Ultrasound Systems Market 2021-2031 by Component (Hardware, Software), Product Type (Diagnostic, Therapeutic), Technology (2D, 3D/4D, Others), Portability (Cart/Trolley-Based, P...

Europe next-generation ultrasound systems market was valued at $1,541.9 million in 2021 and will grow by 6.1% annually over 2021-2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies li...

44742 | Healthcare and Social Assistance

North America Next-Generation Ultrasound Systems Market 2021-2031 by Component (Hardware, Software), Product Type (Diagnostic, Therapeutic), Technology (2D, 3D/4D, Others), Portability (Cart/Trolley-B...

North America next-generation ultrasound systems market is projected to grow by 7.2% annually in the forecast period and reach $5,727.8 million by 2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of nov...

44742 | Healthcare and Social Assistance

Global Next-Generation Ultrasound Systems Market 2021-2031 by Component (Hardware, Software), Product Type (Diagnostic, Therapeutic), Technology (2D, 3D/4D, Others), Portability (Cart/Trolley-Based, P...

Global next-generation ultrasound systems market will reach $ 14,974.5 million by 2031, growing by 7.7% annually over 2021-2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies like 3D/...

44742 | Healthcare and Social Assistance

2022-2027 Global and Regional Pharmaceuticals and Excipients Industry Status and Prospects Professional Market Research Report Standard Version

The global Pharmaceuticals and Excipients market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

6/13/2022 | Pharma & Healthcare

2022-2027 Global and Regional Skin Rejuvenation System Industry Status and Prospects Professional Market Research Report Standard Version

The global Skin Rejuvenation System market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...

5/11/2022 | Pharma & Healthcare

First
Previous
1
2
3
4
5
6
7
8
9
10
Next

Asia Pacific nutrigenomics market will grow by 16.9% annually with a total addressable market cap of $4,313.0 million over 2022-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 32 tables and 58 figures, this 121-page report “Asia Pacific Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Country. Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Products o Probiotics o Prebiotics o Vitamins & Supplements • Testing Services o Nutrigenomics Clinical Testing o Nutrigenomics Research Testing Based on Test Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Next-generation Sequencing • Real-time PCR • DNA Microarray • Sanger Sequencing By Test Sample, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Buccal Swab Sample • Saliva Sample • Blood Sample • Other Samples By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Women’s Health • Metabolic Disorders • Immune Health • Cancer Research • Cardiovascular Diseases • Diabetes • Other Applications By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Nutrition Clinics • Diagnostics Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering，Application and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BASF SE BioGaia Cell Logic Cura Integrative Medicine DNAfit DuPont de Nemours, Inc. Garden of Life, LLC GeneOmbio Genova Diagnostics, Inc. GX Sciences, Inc. Ingredion Incorporated Jarrow Formulas Inc. Koninklijke DSM N.V. MedGenome Metagenics, Inc. Nutrigenomix Inc. Unilever Group XCODE Life Yakult Honsha Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Europe nutrigenomics market was valued at $187.2 million in 2021 and will grow by 14.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 35 tables and 59 figures, this 122-page report “Europe Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Country. Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Products o Probiotics o Prebiotics o Vitamins & Supplements • Testing Services o Nutrigenomics Clinical Testing o Nutrigenomics Research Testing Based on Test Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Next-generation Sequencing • Real-time PCR • DNA Microarray • Sanger Sequencing By Test Sample, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Buccal Swab Sample • Saliva Sample • Blood Sample • Other Samples By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Women’s Health • Metabolic Disorders • Immune Health • Cancer Research • Cardiovascular Diseases • Diabetes • Other Applications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Nutrition Clinics • Diagnostics Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering，Application and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BASF SE BioGaia Cell Logic Cura Integrative Medicine DNAfit DuPont de Nemours, Inc. Garden of Life, LLC GeneOmbio Genova Diagnostics, Inc. GX Sciences, Inc. Ingredion Incorporated Jarrow Formulas Inc. Koninklijke DSM N.V. MedGenome Metagenics, Inc. Nutrigenomix Inc. Unilever Group XCODE Life Yakult Honsha Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

North America nutrigenomics market is projected to grow by 14.8% annually in the forecast period and reach $986.4 million by 2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 25 tables and 55 figures, this 115-page report “North America Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Country. Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Products o Probiotics o Prebiotics o Vitamins & Supplements • Testing Services o Nutrigenomics Clinical Testing o Nutrigenomics Research Testing Based on Test Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Next-generation Sequencing • Real-time PCR • DNA Microarray • Sanger Sequencing By Test Sample, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Buccal Swab Sample • Saliva Sample • Blood Sample • Other Samples By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Women’s Health • Metabolic Disorders • Immune Health • Cancer Research • Cardiovascular Diseases • Diabetes • Other Applications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Nutrition Clinics • Diagnostics Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering，Application and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BASF SE BioGaia Cell Logic Cura Integrative Medicine DNAfit DuPont de Nemours, Inc. Garden of Life, LLC GeneOmbio Genova Diagnostics, Inc. GX Sciences, Inc. Ingredion Incorporated Jarrow Formulas Inc. Koninklijke DSM N.V. MedGenome Metagenics, Inc. Nutrigenomix Inc. Unilever Group XCODE Life Yakult Honsha Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Global nutrigenomics market will reach $2,691.3 million by 2031, growing by 15.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 86 tables and 91 figures, this 178-page report “Global Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Region. Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Products o Probiotics o Prebiotics o Vitamins & Supplements • Testing Services o Nutrigenomics Clinical Testing o Nutrigenomics Research Testing Based on Test Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Next-generation Sequencing • Real-time PCR • DNA Microarray • Sanger Sequencing By Test Sample, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Buccal Swab Sample • Saliva Sample • Blood Sample • Other Samples By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Women’s Health • Metabolic Disorders • Immune Health • Cancer Research • Cardiovascular Diseases • Diabetes • Other Applications By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Nutrition Clinics • Diagnostics Laboratories • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE，Saudi Arabia， South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Offering，Application and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BASF SE BioGaia Cell Logic Cura Integrative Medicine DNAfit DuPont de Nemours, Inc. Garden of Life, LLC GeneOmbio Genova Diagnostics, Inc. GX Sciences, Inc. Ingredion Incorporated Jarrow Formulas Inc. Koninklijke DSM N.V. MedGenome Metagenics, Inc. Nutrigenomix Inc. Unilever Group XCODE Life Yakult Honsha Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Asia Pacific next-generation ultrasound systems market will grow by 9.8% annually with a total addressable market cap of $ 31,245.5 million over 2022-2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies like 3D/4D and AI/IoT, and snowballing healthcare expenditure and government investments to support the R&D activities. Highlighted with 33 tables and 59 figures, this 120-page report “Asia Pacific Next-Generation Ultrasound Systems Market 2021-2031 by Component (Hardware, Software), Product Type (Diagnostic, Therapeutic), Technology (2D, 3D/4D, Others), Portability (Cart/Trolley-Based, Portable, Handheld and Wearables), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific next-generation ultrasound systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific next-generation ultrasound systems market in every aspect of the classification from perspectives of Component, Product Type, Technology, Portability, Application, End User, and Country. Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hardware • Software Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic Ultrasound Systems • Therapeutic Ultrasound Systems o High-Intensity Focused Ultrasound o Extracorporeal Shock Wave Lithotripsy o Doppler Ultrasound Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • 2D Ultrasound Systems • 3D/4D Ultrasound Systems • Other Technologies By Portability, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Cart/Trolley-Based Systems • Portable Systems • Handheld Devices and Wearables By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • General Imaging • Cardiovascular Imaging • Obstetrics and Gynecology Imaging • Vascular Imaging • Lung Imaging • Urology Imaging • Orthopedics/Musculoskeletal Imaging • Other Applications By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Diagnostic Centers • Ambulatory Surgical Centers (ASCs) • Clinics • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Technology and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BK Medical ApS (Analogic Corporation) Butterfly Network, Inc. Canon, Inc. Claruis Mobile Health Corporation Esaote S.p.A. Fujifilm Holdings Corporation General Electric Company Healcerion Co., Ltd. Hitachi, Ltd. Hologic, Inc. Koninklijke Philips N.V. Samsung Electronics Co., Ltd. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Shimadzu Corporation Siemens Healthineers AG (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Europe next-generation ultrasound systems market was valued at $1,541.9 million in 2021 and will grow by 6.1% annually over 2021-2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies like 3D/4D and AI/IoT, and snowballing healthcare expenditure and government investments to support the R&D activities. Highlighted with 36 tables and 60 figures, this 120-page report “Europe Next-Generation Ultrasound Systems Market 2021-2031 by Component (Hardware, Software), Product Type (Diagnostic, Therapeutic), Technology (2D, 3D/4D, Others), Portability (Cart/Trolley-Based, Portable, Handheld and Wearables), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe next-generation ultrasound systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe next-generation ultrasound systems market in every aspect of the classification from perspectives of Component, Product Type, Technology, Portability, Application, End User, and Country. Based on Component, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hardware • Software Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic Ultrasound Systems • Therapeutic Ultrasound Systems o High-Intensity Focused Ultrasound o Extracorporeal Shock Wave Lithotripsy o Doppler Ultrasound Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • 2D Ultrasound Systems • 3D/4D Ultrasound Systems • Other Technologies By Portability, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Cart/Trolley-Based Systems • Portable Systems • Handheld Devices and Wearables By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • General Imaging • Cardiovascular Imaging • Obstetrics and Gynecology Imaging • Vascular Imaging • Lung Imaging • Urology Imaging • Orthopedics/Musculoskeletal Imaging • Other Applications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Diagnostic Centers • Ambulatory Surgical Centers (ASCs) • Clinics • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Technology and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BK Medical ApS (Analogic Corporation) Butterfly Network, Inc. Canon, Inc. Claruis Mobile Health Corporation Esaote S.p.A. Fujifilm Holdings Corporation General Electric Company Healcerion Co., Ltd. Hitachi, Ltd. Hologic, Inc. Koninklijke Philips N.V. Samsung Electronics Co., Ltd. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Shimadzu Corporation Siemens Healthineers AG (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

North America next-generation ultrasound systems market is projected to grow by 7.2% annually in the forecast period and reach $5,727.8 million by 2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies like 3D/4D and AI/IoT, and snowballing healthcare expenditure and government investments to support the R&D activities. Highlighted with 26 tables and 56 figures, this 113-page report “North America Next-Generation Ultrasound Systems Market 2021-2031 by Component (Hardware, Software), Product Type (Diagnostic, Therapeutic), Technology (2D, 3D/4D, Others), Portability (Cart/Trolley-Based, Portable, Handheld and Wearables), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America next-generation ultrasound systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America next-generation ultrasound systems market in every aspect of the classification from perspectives of Component, Product Type, Technology, Portability, Application, End User, and Country. Based on Component, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hardware • Software Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic Ultrasound Systems • Therapeutic Ultrasound Systems o High-Intensity Focused Ultrasound o Extracorporeal Shock Wave Lithotripsy o Doppler Ultrasound Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • 2D Ultrasound Systems • 3D/4D Ultrasound Systems • Other Technologies By Portability, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Cart/Trolley-Based Systems • Portable Systems • Handheld Devices and Wearables By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • General Imaging • Cardiovascular Imaging • Obstetrics and Gynecology Imaging • Vascular Imaging • Lung Imaging • Urology Imaging • Orthopedics/Musculoskeletal Imaging • Other Applications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Diagnostic Centers • Ambulatory Surgical Centers (ASCs) • Clinics • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Technology and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BK Medical ApS (Analogic Corporation) Butterfly Network, Inc. Canon, Inc. Claruis Mobile Health Corporation Esaote S.p.A. Fujifilm Holdings Corporation General Electric Company Healcerion Co., Ltd. Hitachi, Ltd. Hologic, Inc. Koninklijke Philips N.V. Samsung Electronics Co., Ltd. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Shimadzu Corporation Siemens Healthineers AG (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Global next-generation ultrasound systems market will reach $ 14,974.5 million by 2031, growing by 7.7% annually over 2021-2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies like 3D/4D and AI/IoT, and snowballing healthcare expenditure and government investments to support the R&D activities. Highlighted with 85 tables and 92 figures, this 175-page report “Global Next-Generation Ultrasound Systems Market 2021-2031 by Component (Hardware, Software), Product Type (Diagnostic, Therapeutic), Technology (2D, 3D/4D, Others), Portability (Cart/Trolley-Based, Portable, Handheld and Wearables), Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global next-generation ultrasound systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global next-generation ultrasound systems market in every aspect of the classification from perspectives of Component, Product Type, Technology, Portability, Application, End User, and Region. Based on Component, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hardware • Software Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic Ultrasound Systems • Therapeutic Ultrasound Systems o High-Intensity Focused Ultrasound o Extracorporeal Shock Wave Lithotripsy o Doppler Ultrasound Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • 2D Ultrasound Systems • 3D/4D Ultrasound Systems • Other Technologies By Portability, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Cart/Trolley-Based Systems • Portable Systems • Handheld Devices and Wearables By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • General Imaging • Cardiovascular Imaging • Obstetrics and Gynecology Imaging • Vascular Imaging • Lung Imaging • Urology Imaging • Orthopedics/Musculoskeletal Imaging • Other Applications By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Diagnostic Centers • Ambulatory Surgical Centers (ASCs) • Clinics • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE，Saudi Arabia， South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product Type, Technology and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BK Medical ApS (Analogic Corporation) Butterfly Network, Inc. Canon, Inc. Claruis Mobile Health Corporation Esaote S.p.A. Fujifilm Holdings Corporation General Electric Company Healcerion Co., Ltd. Hitachi, Ltd. Hologic, Inc. Koninklijke Philips N.V. Samsung Electronics Co., Ltd. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Shimadzu Corporation Siemens Healthineers AG (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

The global Pharmaceuticals and Excipients market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Dow Shin-Etsu JRS Pharma BASF Roquette ER-KANG ABITEC Corp Ashland Lubrizol Evonik Signet Chemical Corporation Sigachi Industries MEGGLE AG By Types: Triglycerides Mannitol Sorbitol Sucrose Dextrose Starch Others By Applications: Oral Formulations Topical Formulations Parenteral Formulations Other Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and Drivers: Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements. ...

6/13/2022

The global Skin Rejuvenation System market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Biotec Italia Medicoson Lanaform Corpoderm Healthcare And Beauty Aesthetic Group Anti Aging Medical Systems DJM Medical Instrument By Types: Microdermabrasion Machine Exfoliating Machine Skin Rejuvenation Instrument Others By Applications: Medical Beauty Home Care Others Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and Drivers: Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements. ...

5/11/2022

LATEST REPORTS

PRESS RELEASES

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT